Department of Vascular Surgery, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; PhyMedExp, University of Montpellier, INSERM, CNRS, France.
Department of Vascular Surgery, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1787-1793. doi: 10.1016/j.jtcvs.2018.05.001. Epub 2018 May 17.
The study objective was to assess the midterm outcomes and aortic remodeling in patients with Marfan syndrome with complicated acute type B aortic dissection treated with stent-assisted, balloon-induced intimal disruption and relamination.
We reviewed all patients treated with stent-assisted, balloon-induced intimal disruption and relamination for a complicated acute type B aortic dissection associated with Marfan syndrome according to the revised Ghent criteria.
Between 2015 and November 2017, 7 patients with Marfan syndrome underwent stent-assisted, balloon-induced intimal disruption and relamination for a complicated acute type B aortic dissection. The median age of patients was 47 years (range, 23-70). Four patients had a history of aortic root replacement. Technical success was achieved in 100%. Three patients required an adjunctive procedure for renal artery stenting (n = 2) and iliac artery stenting (n = 1). There was no in-hospital death, 30-day postoperative stroke, spinal cord ischemia, ischemic colitis, or renal failure requiring dialysis. At a median follow-up of 15 months (range, 7-28), 1 patient required aortic arch replacement for aneurysmal degeneration associated with a type Ia endoleak at 2 years, giving a late reintervention rate of 14%. There was no other secondary endoleak. The primary visceral patency rate was 100%. There were no all-cause deaths reported. At last computed tomography scan, all patients had complete aortic remodeling of the treated thoracoabdominal aorta. Distally, at the nonstented infrarenal aortoiliac level, 6 patients had persistent false lumen flow with stable aorto-iliac diameter in 5. One patient had iliac diameter growth (27 mm diameter at last computed tomography scan).
Stent-assisted, balloon-induced intimal disruption and relamination of aortic dissection in patients with Marfan syndrome is feasible, safe, and associated with an immediate and midterm persisting thoracoabdominal aortic remodeling.
本研究旨在评估支架辅助、球囊诱导内膜撕裂和再层化治疗马凡综合征合并复杂急性 B 型主动脉夹层的中期结果和主动脉重塑情况。
我们回顾了根据修订后的根特标准,所有接受支架辅助、球囊诱导内膜撕裂和再层化治疗的马凡综合征合并复杂急性 B 型主动脉夹层患者的资料。
2015 年至 2017 年 11 月,7 例马凡综合征患者因复杂急性 B 型主动脉夹层而行支架辅助、球囊诱导内膜撕裂和再层化治疗。患者中位年龄 47 岁(范围,23-70 岁)。4 例患者有主动脉根部置换史。技术成功率达 100%。3 例患者因肾动脉支架置入术(n=2)和髂动脉支架置入术(n=1)需要辅助治疗。无院内死亡、30 天术后卒中、脊髓缺血、缺血性结肠炎或需要透析的肾衰竭。中位随访 15 个月(范围,7-28 个月),1 例患者因 2 年时与 Ia 型内漏相关的动脉瘤样变需要行主动脉弓置换,晚期再介入率为 14%。无其他次要内漏。主要内脏通畅率为 100%。无全因死亡报告。末次 CT 扫描时,所有患者胸腹部主动脉的治疗均完全重塑。在未支架置入的肾下腹主动脉水平,6 例患者仍存在假腔血流,5 例患者腹主动脉-髂动脉直径稳定。1 例患者髂动脉直径增大(末次 CT 扫描时为 27mm)。
支架辅助、球囊诱导内膜撕裂和再层化治疗马凡综合征合并主动脉夹层是可行、安全的,且与即刻和中期胸腹部主动脉持续重塑相关。